$599

CMS Delays Launch of Obesity BALANCE Model; Sanofi’s Tzield Receives Black Box Warning Following Pediatric Label Expansion; Beta Bionics Q1 ’26 Earnings; Pfizer’s Ecnoglutide Injection Available for Pre-Order in China

A series of cardiometabolic-related news items has been observed from CMS, Sanofi, Beta Bionics, and Pfizer. Below, FENIX provides highlights and insights for the respective news items.

This content is for Read Less members only.
Register
Already a member? Log in here